Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.
Vaccines in Multiple Sclerosis.
Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
Tysabri® (natalizumab) data at ECTRIMS reaffirm positive effects of treatment for people with relapsing forms of MS
The antiviral drug ganciclovir does not inhibit microglial proliferation and activation.
Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.
Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.
Guwiyang Wurra-'Fire Mouse': a global gene knockout model for TSPO/PBR drug development, loss-of-function and mechanisms of compensation studies.
Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C.
Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy.
Developmental regulation of insulin receptor gene in sciatic nerves and role of insulin on glycoprotein P0 in the Schwann cells.
High nationwide incidence of multiple sclerosis in sweden.
Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis.
Cover picture: eur. J. Immunol. 5'15.
Possible Relations Between Epstein-Barr Virus Past Infection and Classic Multiple Sclerosis in Guilan, Iran.
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.
Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Can hand dexterity predict the disability status of patients with multiple sclerosis?
Multiple Sclerosis.
Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease.
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.
Another Case of PML with Gilenya Reported by Novartis
Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases.

Pages